Prognostic factors for survival after curative resection of Dukes' B colonic cancer

Colorectal Disease

Volumn 13, Issue 12, 2011, Pages 1390-1394

  Saha, A K ^a   Smith, K J E ^a   Sue Ling, H ^a   Sagar, P M ^a   Burke, D ^a   Finan, P J ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

Dukes' B; Lymph node yield; Node negative colon cancer

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; COLON CANCER; FEMALE; FOLLOW UP; HAZARD RATIO; HUMAN; HUMAN TISSUE; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CHEMOTHERAPY, ADJUVANT; COLONIC NEOPLASMS; FEMALE; HUMANS; INTESTINAL PERFORATION; KAPLAN-MEIER ESTIMATE; LYMPH NODE EXCISION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS;

EID: 80755126931     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/j.1463-1318.2010.02507.x     Document Type: Article

References (21)

1. Dukes CE. The classification of cancer of the rectum. J Pathol Bacteriol 1932; 35: 323-32.
2. Astler VB, Coller FA. The prognostic significance of direct extension of carcinoma of the colon and rectum. Ann Surg 1954; 139: 846-51.
3. Jass JR, Love SB, Northover JMA. A new prognostic classification in rectal cancer. Lancet 1987; 1: 1303-6.
4. Engstrom PF, Benson AB 3rd, Chen YJ et al. Colon cancer clinical practice guidelines in oncology. J Natl Compr Canc Netw 2005; 3: 468-91.
5. O'Connell MJ, Schaid DJ, Ganju V et al. Current status of adjuvant therapy of colorectal cancer: can molecular markers play a role in predicting prognosis? Cancer 1992; 70(Suppl.): 1732-9.
6. O'Connell JB, Maggard MA, Ko CY. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst 2004; 96: 1420-5.
7. Berger AC, Sigurdson ER, LeVoyer T et al. Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes. J Clin Oncol 2005; 23: 8706-12.
8. Grady WM. Genomic instability and colon cancer. Cancer Metastasis Rev 2004; 2: 11-27.
9. Buyse M, Piedbois P. Should Dukes' B patients receive adjuvant therapy? A statistical perspective. Semin Oncol 2001; 28(1 Suppl. 1): 20-4.
10. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-81.
11. Kirklin JW, Dockerty MB, Waugh JM. The role of the peritoneal reflection in the prognosis of carcinoma of the rectum and sigmoid colon. Surg Gynecol Obstet 1949; 88: 326-31.
12. Prandi M, Lionetto R, Bini A et al. Prognostic evaluation of stage B colon cancer patients is improved by an adequate lymphadenectomy: results of a secondary analysis of a large scale adjuvant trial. Ann Surg 2002; 235: 458-63.
13. Maggard MA, Yermilov I, Tomlinson JS, Ko CY. Are 12 nodes needed to accurately stage T1 and T2 colon cancers? Dig Dis Sci 2009; 54: 640-7.
14. Kim HJ, Lee IK, Lee YS et al. A comparative study on the short-term clinicopathologic outcomes of laparoscopic surgery versus conventional open surgery for transverse colon cancer. Surg Endosc 2009; 23: 1812-7.
15. Merkel S, Wein A, Günther K et al. High-risk groups of patients with Stage II colon carcinoma. Cancer 2001; 92: 1435-43.
16. West NP, Morris EJA, Rotimi O et al. Pathology grading of colon cancer surgical resection and its association with survival: a retrospective observational study. Lancet Oncol 2008; 9: 857-65.
17. West NP, Hohenberger W, Weber K et al. Complete mesocolic excision with central vascular ligation produces an oncologically superior specimen compared with standard surgery for carcinoma of the colon. J Clin Oncol 2010; 28: 272-8.
18. Carraro PG, Segala M, Orlotti C, Tiberio G. Outcome of large bowel perforation in patients with colorectal cancer. Dis Colon Rectum 1998; 41: 1421-6.
19. Abdelrazeq AS, Scott N, Thorn C et al. The impact of spontaneous tumour perforation on outcome following colon cancer surgery. Colorectal Dis 2008; 10: 775-80.
20. Figueredo A, Coombes ME, Mukherjee S. Adjuvant therapy for completely resected stage II colon cancer. Cochrane Database Syst Rev 2008:CD005390.
21. Fluoropyrimidine, Oxaliplatin & Targeted Receptor pre-Operative Therapy for colon cancer (FOxTROT) Trial Protocol, Version 3. UK National Cancer Research Institute Colorectal Cancer Clinical Studies Group. Accessed online 25 November 2010.